AU Patent

AU2014248849B2 — Treatment of cataplexy

Assigned to Jazz Pharmaceuticals Ireland Ltd · Expires 2018-08-30 · 8y expired

What this patent protects

The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.

USPTO Abstract

The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014248849B2
Jurisdiction
AU
Classification
—
Expires
2018-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.